ATP‐sensitive K+ channels: Pharmacologic properties, regulation, and therapeutic potential
- 1 February 1993
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 28 (2), 95-127
- https://doi.org/10.1002/ddr.430280202
Abstract
No abstract availableThis publication has 230 references indexed in Scilit:
- The potassium channel opener BRL 38227 inhibits binding of [125I]-labelled endothelin-1 to rat cardiac membranesBiochemical and Biophysical Research Communications, 1992
- Angiotensin II blocks ATP-sensitive K+ channels in porcine coronary artery smooth muscle cellsBiochemical and Biophysical Research Communications, 1991
- Hippocampal potassium ATP channels and anoxia: presynaptic, postsynaptic or both?Trends in Neurosciences, 1990
- PinacidilDrugs, 1990
- ATP-sensitive K+ channels reveal the effects of intracellular chloride variations on cytoplasmic ATP concentrations and mitochondrial functionBiochemical and Biophysical Research Communications, 1990
- The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytesBiochemical and Biophysical Research Communications, 1988
- Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog.JCI Insight, 1987
- Cloning of Genomic and Complementary DNA from Shaker , a Putative Potassium Channel Gene from DrosophilaScience, 1987
- The antidiabetic sulfonylurea glibenclamide is a potent blocker of the ATP-modulated K+ channel in insulin secreting cellsBiochemical and Biophysical Research Communications, 1987
- Use of topical minoxidil in the treatment of male pattern baldnessJournal of the American Academy of Dermatology, 1987